rdf:type |
|
lifeskim:mentions |
umls-concept:C0001554,
umls-concept:C0013018,
umls-concept:C0014792,
umls-concept:C0038250,
umls-concept:C0079459,
umls-concept:C0229664,
umls-concept:C0242602,
umls-concept:C0439148,
umls-concept:C1515895,
umls-concept:C1709450,
umls-concept:C1709854
|
pubmed:issue |
11
|
pubmed:dateCreated |
2001-11-5
|
pubmed:abstractText |
It may be useful to reduce the exposure of transplant recipients to homologous blood. This may be achieved by procuring donor-derived red blood cell (RBC) units, collecting more peripheral blood progenitor cells (PBPC) with a combination of granulocyte colony-stimulating factor (G-CSF) + recombinant human erythropoietin (rHuEpo) and by administering rHuEpo post-transplantation.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0390-6078
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
86
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1209-18
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:11694408-Adolescent,
pubmed-meshheading:11694408-Adult,
pubmed-meshheading:11694408-Blood Donors,
pubmed-meshheading:11694408-Cytapheresis,
pubmed-meshheading:11694408-Erythrocyte Transfusion,
pubmed-meshheading:11694408-Erythropoietin,
pubmed-meshheading:11694408-Feasibility Studies,
pubmed-meshheading:11694408-Female,
pubmed-meshheading:11694408-Graft Survival,
pubmed-meshheading:11694408-Granulocyte Colony-Stimulating Factor,
pubmed-meshheading:11694408-Hematopoietic Stem Cell Mobilization,
pubmed-meshheading:11694408-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:11694408-Humans,
pubmed-meshheading:11694408-Leukapheresis,
pubmed-meshheading:11694408-Male,
pubmed-meshheading:11694408-Middle Aged,
pubmed-meshheading:11694408-Prospective Studies,
pubmed-meshheading:11694408-Recombinant Proteins,
pubmed-meshheading:11694408-Transplantation, Homologous
|
pubmed:year |
2001
|
pubmed:articleTitle |
Administration of erythopoietin and granulocyte colony-stimulating factor in donor/recipient pairs to collect peripheral blood progenitor cells (PBPC) and red blood cell units for use in the recipient after allogeneic PBPC transplantation.
|
pubmed:affiliation |
Department of Medicine, Division of Haematology, University of Liège, Liège, Belgium.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|